Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate as adjunctive therapy in partial onset seizures
NCT00697762Phase 3Terminated
- Sponsor
- SK Life Science, Inc.
- Start
- Oct 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of carisbamate in epilepsy, sponsored by SK Life Science, Inc.. Started Oct 2007; status: terminated.
02
Drugs
carisbamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00697762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697762.